'Reference gene' presentation slideshows

REAL TIME PCR

REAL TIME PCR. USING SYBR GREEN. THE PROBLEM. NEED TO QUANTITATE DIFFERENCES IN mRNA EXPRESSION SMALL AMOUNTS OF mRNA LASER CAPTURE SMALL AMOUNTS OF TISSUE PRIMARY CELLS PRECIOUS REAGENTS. THE PROBLEM. QUANTITATION OF mRNA northern blotting ribonuclease protection assay

902 views • 77 slides

REAL TIME PCR

REAL TIME PCR. USING SYBR GREEN. THE PROBLEM. NEED TO QUANTITATE DIFFERENCES IN mRNA EXPRESSION SMALL AMOUNTS OF mRNA LASER CAPTURE SMALL AMOUNTS OF TISSUE PRIMARY CELLS PRECIOUS REAGENTS. THE PROBLEM. QUANTITATION OF mRNA northern blotting ribonuclease protection assay

964 views • 77 slides

REAL TIME PCR

REAL TIME PCR. USING SYBR GREEN. THE PROBLEM. NEED TO QUANTITATE DIFFERENCES IN mRNA EXPRESSION SMALL AMOUNTS OF mRNA LASER CAPTURE SMALL AMOUNTS OF TISSUE PRIMARY CELLS PRECIOUS REAGENTS. THE PROBLEM. QUANTITATION OF mRNA northern blotting ribonuclease protection assay

836 views • 77 slides

Litao Yang, Dabing Zhang , zhen Li College of Life Science and Biotechnology

China-UK Bilateral Workshop on Modern Biology & its Social Impact. Activities of GMOs analysis in China. Litao Yang, Dabing Zhang , zhen Li College of Life Science and Biotechnology. Authorized AgGMOs in the world and China AgGMOs regulation and labeling in China GMOs analysis:

683 views • 52 slides

Establishment of National Genetically Modified Product Detection Laboratories and Detection Method Complex

Establishment of National Genetically Modified Product Detection Laboratories and Detection Method Complex. ZHU Shui-fang, Ph.D GMOs detection center Institute of Animal and Plant Quarantine. Research contents. 1. Detection technology of GMOs Real-time PCR DNA Microarray

608 views • 27 slides

Quantitative multi-gene expression profiling of primary prostate cancer*

114 views • 1 slides

urologie.uniklinikum-dresden.de, *e-mail: doreen.kunze@uniklinikum-dresden.de

(a). siRNA-D5. ns-siRNA. untreated. PSA/TBP. p38MAPK. C13orf19/TBP. ?-Actin. phospho-p38MAPK. (b). 3.6 %. 3.9 %. 3.5 %. time (h). time (h). ?-Actin. b). 72 h. a).

148 views • 1 slides

Functional analyses of C13orf19 in prostate cell lines

(a). siRNA-D5. untreated. ns-siRNA. PSA/TBP. p38MAPK. C13orf19/TBP. ?-Actin. phospho-p38MAPK. (b). 3.6 %. 3.9 %. 3.5 %. time (h). time (h). ?-Actin. http://urologie.uniklinikum-dresden.de, e-mail: doreen.kunze@uniklinikum-dresden.de. b). 72 h. a).

99 views • 1 slides

urologie.uniklinikum-dresden.de, e-mail: doreen.kunze@uniklinikum-dresden.de

(a). siRNA-D5. ns-siRNA. untreated. PSA/TBP. p38MAPK. C13orf19/TBP. ?-Actin. phospho-p38MAPK. (b). 3.6 %. 3.9 %. 3.5 %. time (h). time (h). ?-Actin. b). 72 h. a).

119 views • 1 slides

urologie.uniklinikum-dresden.de, *e-mail: doreen.kunze@uniklinikum-dresden.de

(a). siRNA-D5. ns-siRNA. untreated. PSA/TBP. p38MAPK. C13orf19/TBP. ?-Actin. phospho-p38MAPK. (b). 3.6 %. 3.9 %. 3.5 %. time (h). time (h). ?-Actin. b). 72 h. a). 1.3 %. 1.6 %. 0.8 %. Material and Methods II:

151 views • 1 slides

urologie.uniklinikum-dresden.de, e-mail: doreen.kunze@uniklinikum-dresden.de

(a). siRNA-D5. ns-siRNA. untreated. PSA/TBP. p38MAPK. C13orf19/TBP. ?-Actin. phospho-p38MAPK. (b). 3.6 %. 3.9 %. 3.5 %. time (h). time (h). ?-Actin. b). 72 h. a).

190 views • 1 slides